M&A Deal Summary

Myriad Acquires Assurex Health

On August 3, 2016, Myriad acquired life science company Assurex Health for 225M USD

Acquisition Highlights
  • This is Myriad’s 3rd transaction in the Life Science sector.
  • This is Myriad’s 3rd largest (disclosed) transaction.
  • This is Myriad’s 3rd transaction in the United States.
  • This is Myriad’s 1st transaction in Ohio.

M&A Deal Summary
Date 2016-08-03
Target Assurex Health
Sector Life Science
Buyer(s) Myriad
Deal Type Add-on Acquisition
Deal Value 225M USD

Target

Assurex Health

Mason, Ohio, United States
Assurex Health, Inc. is an informatics-based precision medicine company providing treatment decision support to healthcare providers for mental health. Assurex Health’s lead product, GeneSight® Psychotropic, evaluates 12 genes known to play a significant role in psychotropic drug response, and utilizing a proprietary combinatorial pharmacogenomics approach called CPGx, assigns patients into one of over 300,000 unique composite phenotypes.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Myriad

Salt Lake City, Utah, United States
Category Company
Founded 1991
Sector Life Science
Employees2,700
Revenue 753M USD (2023)
DESCRIPTION

Myriad is a molecular diagnostic company discovers and commercialize a transformative tests to assess a person's risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence. Myriad was founded in 1991 and is based in Salt Lake City, Utah.

DEAL STATS #
Overall 4 of 6
Sector (Life Science) 3 of 4
Type (Add-on Acquisition) 3 of 4
State (Ohio) 1 of 1
Country (United States) 3 of 5
Year (2016) 2 of 2
Size (of disclosed) 3 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-05-31 Sividon Diagnostics

Cologne, Germany

Sividon Diagnostics GmbH is a breast cancer prognostic company products medical products.

Buy €35M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-05-28 Counsyl

San Francisco, California, United States

Counsyl is a provider of an actionable information that guides women and their families in making critical and timely health decisions. Counsyl operates a high-complexity clinical laboratory that offers the Foresight™ Carrier Screen, Prelude™ Prenatal Screen and Reliant™ Cancer Screen, as well as supporting services through Counsyl Complete™, a proprietary suite of solutions, designed to seamlessly integrate Counsyl screening into clinic workflows and patients’ lives. Counsyl is based in San Francisco, California.

Buy $375M
Mergr

Product

Company

Legal